Advisory groups ask shareholders to oppose bid to raise Pascal Soriots maximum share bonus to 650% of 1.3m basic payAstraZeneca is facing mounting opposition over its plans to award its chief executive, Pascal Soriot, a big increase in bonuses, with two investor advisory groups advising shareholders...

https://www.theguardian.com/business/2021/may/04/obscene-bonus-hike-for-astrazeneca-boss-prompts-investor-anger

#theguardian